Ai Shirai, Yuya Nakatani, Shuji Toya, Ichiro Ogura
{"title":"Sjögren综合征患者腮腺的磁共振涎腺造影和唾液腺SPECT/CT。","authors":"Ai Shirai, Yuya Nakatani, Shuji Toya, Ichiro Ogura","doi":"10.1093/dmfr/twaf048","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate MR sialography and SPECT/CT for parotid glands in Sjögren's syndrome patients.</p><p><strong>Methods: </strong>Thirty Sjögren's syndrome patients underwent MR sialography and SPECT/CT. The MR sialographic stagings of Sjögren's syndrome were determined by the criteria (stage 0: normal; stage 1: punctate appearance; stage 2: globular appearance; stage 3: cavitary appearance; stage 4: destructive appearance). The maximum standardized uptake value (SUVmax) of the right and left parotid glands with SPECT/CT was obtained using a workstation and software. MR sialographic stagings and SUVmax of parotid glands were evaluated at pre- and post-stimulation and ratio of pre- to post-stimulation.</p><p><strong>Results: </strong>Regarding pre-stimulation, the SUVmax of stage 0 (31.9 ± 19.3) was significantly higher than that of stage 2 (19.7 ± 7.5, p = 0.046), stage 3 (10.2 ± 7.1, p < 0.001) and stage 4 (6.8 ± 4.3, p < 0.001). Furthermore, the SUVmax at ratio of pre- to post-stimulation of stage 0 (1.87 ± 0.55) was significantly higher than that of stage 3 (1.16 ± 0.30, p = 0.001) and stage 4 (1.16 ± 0.40, p < 0.001).</p><p><strong>Conclusion: </strong>This study suggests that MR sialography and SPECT/CT SUV are effective tool for the management of Sjögren's syndrome patients.</p>","PeriodicalId":11261,"journal":{"name":"Dento maxillo facial radiology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Magnetic resonance sialography and salivary gland SPECT/CT for parotid glands in patients with Sjögren's syndrome.\",\"authors\":\"Ai Shirai, Yuya Nakatani, Shuji Toya, Ichiro Ogura\",\"doi\":\"10.1093/dmfr/twaf048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this study was to investigate MR sialography and SPECT/CT for parotid glands in Sjögren's syndrome patients.</p><p><strong>Methods: </strong>Thirty Sjögren's syndrome patients underwent MR sialography and SPECT/CT. The MR sialographic stagings of Sjögren's syndrome were determined by the criteria (stage 0: normal; stage 1: punctate appearance; stage 2: globular appearance; stage 3: cavitary appearance; stage 4: destructive appearance). The maximum standardized uptake value (SUVmax) of the right and left parotid glands with SPECT/CT was obtained using a workstation and software. MR sialographic stagings and SUVmax of parotid glands were evaluated at pre- and post-stimulation and ratio of pre- to post-stimulation.</p><p><strong>Results: </strong>Regarding pre-stimulation, the SUVmax of stage 0 (31.9 ± 19.3) was significantly higher than that of stage 2 (19.7 ± 7.5, p = 0.046), stage 3 (10.2 ± 7.1, p < 0.001) and stage 4 (6.8 ± 4.3, p < 0.001). Furthermore, the SUVmax at ratio of pre- to post-stimulation of stage 0 (1.87 ± 0.55) was significantly higher than that of stage 3 (1.16 ± 0.30, p = 0.001) and stage 4 (1.16 ± 0.40, p < 0.001).</p><p><strong>Conclusion: </strong>This study suggests that MR sialography and SPECT/CT SUV are effective tool for the management of Sjögren's syndrome patients.</p>\",\"PeriodicalId\":11261,\"journal\":{\"name\":\"Dento maxillo facial radiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dento maxillo facial radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/dmfr/twaf048\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dento maxillo facial radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/dmfr/twaf048","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Magnetic resonance sialography and salivary gland SPECT/CT for parotid glands in patients with Sjögren's syndrome.
Objective: The aim of this study was to investigate MR sialography and SPECT/CT for parotid glands in Sjögren's syndrome patients.
Methods: Thirty Sjögren's syndrome patients underwent MR sialography and SPECT/CT. The MR sialographic stagings of Sjögren's syndrome were determined by the criteria (stage 0: normal; stage 1: punctate appearance; stage 2: globular appearance; stage 3: cavitary appearance; stage 4: destructive appearance). The maximum standardized uptake value (SUVmax) of the right and left parotid glands with SPECT/CT was obtained using a workstation and software. MR sialographic stagings and SUVmax of parotid glands were evaluated at pre- and post-stimulation and ratio of pre- to post-stimulation.
Results: Regarding pre-stimulation, the SUVmax of stage 0 (31.9 ± 19.3) was significantly higher than that of stage 2 (19.7 ± 7.5, p = 0.046), stage 3 (10.2 ± 7.1, p < 0.001) and stage 4 (6.8 ± 4.3, p < 0.001). Furthermore, the SUVmax at ratio of pre- to post-stimulation of stage 0 (1.87 ± 0.55) was significantly higher than that of stage 3 (1.16 ± 0.30, p = 0.001) and stage 4 (1.16 ± 0.40, p < 0.001).
Conclusion: This study suggests that MR sialography and SPECT/CT SUV are effective tool for the management of Sjögren's syndrome patients.
期刊介绍：
Dentomaxillofacial Radiology (DMFR) is the journal of the International Association of Dentomaxillofacial Radiology (IADMFR) and covers the closely related fields of oral radiology and head and neck imaging.
Established in 1972, DMFR is a key resource keeping dentists, radiologists and clinicians and scientists with an interest in Head and Neck imaging abreast of important research and developments in oral and maxillofacial radiology.
The DMFR editorial board features a panel of international experts including Editor-in-Chief Professor Ralf Schulze. Our editorial board provide their expertise and guidance in shaping the content and direction of the journal.
Quick Facts:
- 2015 Impact Factor - 1.919
- Receipt to first decision - average of 3 weeks
- Acceptance to online publication - average of 3 weeks
- Open access option
- ISSN: 0250-832X
- eISSN: 1476-542X
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
